Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Ether doai
Patent
1998-07-14
1999-11-09
Weddington, Kevin E.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Ether doai
A61K 31075
Patent
active
059816040
ABSTRACT:
The subject invention pertains to materials and methods for inhibiting bacterial growth. Specifically provided are compounds which control bacteria by interfering with cell wall synthesis.
REFERENCES:
patent: 3665040 (1972-05-01), Ruegg et al.
patent: 5780516 (1998-07-01), Allen et al.
Cain, Brian D., Peter J. Norton, Willis Eubanks, Harry S. Nick, Charles M. Allen (1993) "Amplification of the bacA Gene Confers Bacitracin Resistance to Escherichia coli" Journal of Bacteriology 175:123784-3789.
Cornelissen, F., H. Van den Bossche (1983) "Synergism of the Antimicrobial Agents Miconazole, Bacitracin and Polymyxin B" Chemotherapy 29(6)419-427.
Kalin, Jack R., Charles M. Allen (1980) "Lipid Activation Of Undecaprenol Kinase From Lactobacillus plantarum" Biochimica et Bioophysica Acta 619:76-89.
H. Van Den Bossche, W.F. Lauwers, F. Cornelissen (1982) "The antimycotic miconazole: an inhibitor of the biosynthesis of polyisoprenoids in Staphylococcus aureus" Arch. Int. Physiol. Biochim 90:b78.
Allen Charles M.
Nick Harry S.
University of Florida
Weddington Kevin E.
LandOfFree
Materials and methods for inhibiting bacterial cell wall biosynt does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Materials and methods for inhibiting bacterial cell wall biosynt, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Materials and methods for inhibiting bacterial cell wall biosynt will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1456894